COVID-19 Lockdown Exit Analysis

Subscribe
Get in touch

Before you go we'd just like to ask you a quick question!

Your vote has been counted in the results below.

If you could vote on Brexit now which option would you choose?
Remain Leave

CureVac set to begin phase 3 COVID-19 vaccine study in healthcare workers

CureVac is set to launch a new phase 3 study of its COVID-19 vaccine in healthcare workers at the University Medical Center Mainz in Germany. The Tübingen, Germany-headquartered company expects to vaccinate the first participant in this phase 3 study on 22 December 2020.

PMLiVE - December 21, 2020

View the full story here: https://www.pmlive.com/pharma_news/curevac_set_to_begin_phase_3_covid-19_vaccine_study_in_healthcare_workers_1360354

Contact Us

lockdown_exit@nfind.uk
Our contact form
Curator login

Quick Links

Privacy policy
Terms & Conditions
Cookie Policies

© lockdown_exit 2026. All Right Reserved

Keep up to date with COVID-19 Lockdown Exit Analysis

Name*

Email*

Region*

Enter your region from the drop-down menu so we can tailor the news to you.

Privacy Policy | Terms & Conditions | Cookie Policies

Select or add an image to the Image library

Show only large

Search image library using the following tags

Cookie Notice - News Finder - lockdown_exit

We use cookies to enhance your visit to our site.
Read our Privacy policy, Cookie Policies and Terms & Conditions to find out more.